NYSE$SEM

Select Medical Holdings Corporation · Q2 2025 earnings

Q2 2025 earnings · · After market close · Investor relations

Briefing

Select Medical Holdings Corporation reported revenue of $1.34 billion and net income of $40.6 million for the second quarter of 2025.

The company achieved revenue growth of 4.5% year-over-year driven primarily by its rehabilitation hospital segment. Income from continuing operations before other income and expense increased to $86.5 million. Adjusted EBITDA remained stable at $125.4 million despite higher labor costs in the critical illness recovery hospital segment.

  • Revenue reached $1.34 billion, up 4.5% from Q2 2024, led by 17.2% growth in the rehabilitation hospital segment.
  • Net income attributable to common stockholders was $40.6 million, or $0.32 per share.
  • Critical illness recovery hospital segment saw revenue decline 0.6% and Adjusted EBITDA margin compress to 9.4% due to higher labor costs and Medicare rate pressure.
  • Rehabilitation hospital segment delivered strong performance with 17.2% revenue growth and 22.6% Adjusted EBITDA margin.

Headline financials

Total Revenue

$1.34B

Previous: $1.76B-23.9%
EPS (adj)

$0.32

Previous: $0.60-46.7%
Net Income

$40.6M

Previous: $77.6M-47.7%
Operating Income

$86.5M

Previous: $158M-45.2%
Cash & Equivalents

$52.3M

Previous: $111M-52.9%
Total Assets

$5.74B

Previous: $7.88B-27.1%

Revenue & EPS history

Select Medical · Revenue · Quarterly

$1.34B

Q2 2025-23.9%vs Q2 2024
Beat estimate in 9 of 16 quarters(56%)
ActualEstimate

Revenue by segment

Select Medical · $1.24B total across 3 segments · Q2 2025

  • Critical Illness Recovery Hospital
    $601M
  • Outpatient Rehabilitation
    $328M
  • Rehabilitation Hospital
    $314M

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 19 quarterly earnings reports

Historical avg

-0.3%

Avg return

Earnings day

+0.1%

Avg return

5 days after

+0.5%

Avg return

30 days after

49%

32 / 65 earnings

Positive

+18.8%

Q3 2018

Best reaction

-22.2%

Q1 2025

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q2 2025
Q1 2026+0.2%+0.1%+0.7%
Q4 2025-6.5%-7.3%+1.1%
Q3 2025-5.8%-5.1%+9.1%
Q1 2025-22.2%-17.7%-16.2%
Q4 2024-7.2%-2.9%-13.1%
Q3 2024+9.4%+13.3%+19.3%
Q2 2024-14.0%-17.2%-9.3%
Q1 2024+12.3%+17.0%+23.5%
Q4 2023+6.7%+4.6%+7.7%
Q3 2023-1.2%-2.7%+3.9%
Q2 2023-1.3%-2.5%-4.3%
Q1 2023+4.8%-0.8%-2.8%
Q4 2022-7.8%-9.1%-17.6%
Q3 2022-6.5%-10.9%+0.9%
Q2 2022-4.1%-11.1%-14.7%
Q1 2022+0.9%-4.2%+10.6%
Q4 2021+1.1%+2.2%+3.5%
Q3 2021+2.4%-0.9%-18.4%
Q2 2021-3.3%-6.9%-7.7%
Q1 2021-2.5%-3.1%+4.9%
Q4 2020+10.5%+16.9%+20.5%
Q3 2020-1.7%+8.5%+15.4%
Q2 2020+13.1%+14.7%+21.2%
Q1 2020-15.3%-12.9%-6.3%
Q4 2019+8.9%-0.1%-55.6%
Q3 2019+5.7%+10.6%+22.9%
Q2 2019-5.8%-5.8%-3.1%
Q1 2019+1.7%+3.0%-1.3%
Q4 2018+0.1%-4.8%-10.1%
Q3 2018+18.8%+21.2%+16.9%
Q2 2018-5.0%-7.5%-6.6%
Q1 2018-4.4%-3.5%-2.9%
Q4 2017+11.2%+11.4%+7.8%
Q3 2017-7.8%-9.4%-6.5%
Q2 2017+8.6%+12.7%+18.7%
Q1 2017+5.9%+1.1%+3.7%
Q4 2016+9.6%+11.6%-3.1%
Q3 2016-8.2%-6.1%-1.2%
Q2 2016+10.6%+6.3%+9.3%
Q1 2016-4.5%
Q4 2015+10.9%
Q3 2015+5.0%
Q2 2015+0.1%
Q1 2015+0.0%
Q4 2014-5.2%
Q3 2014+11.3%
Q2 2014-12.4%
Q1 2014+0.5%
Q4 2013+1.7%
Q3 2013+1.1%
Q2 2013+1.3%
Q1 2013-2.5%
Q4 2012+4.0%
Q3 2012+10.0%
Q2 2012+9.1%
Q1 2011-3.2%
Q1 2012+1.1%
Q4 2009-0.4%
Q4 2011-0.4%
Q3 2010-2.4%
Q3 2011-2.4%
Q2 2011-15.8%
Q2 2010-15.8%
Q4 2010-15.8%
Q1 2010-7.2%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro